The Tel Aviv Stock Exchange fell today. The Tel Aviv 25 Index fell 0.96%, to 1,453.84 points; the Tel Aviv 100 Index fell 0.95%, to 1,281.38 points; and the BlueTech Index fell 0.91%, to 352.51 points. The TelBond 20 corporate bond index rose 0.08%, to 323.75 points. Turnover totaled NIS 1.5 billion.
The Tel Aviv 25 Index fell 1.0% over the past week. The index is down 4.9% for the year to date.
On the foreign exchange market, the representative shekel-dollar rate was set 0.16% lower, at NIS 3.7680/$, and the representative shekel-euro rate was set 0.10% higher, at NIS 4.2549/€.
Teva led trading, and fell heavily, by 3.31%, following news that a US court had invalidated patents on double-dosage Copaxone, the company's blockbuster multiple sclerosis treatment. Bezeq fell 1.19%. The big two banks rose: Hapoalim by 0.05% and Leumi by 0.28%. Perrigo was another steep decliner, closing 2.35% off, while MannKind fell 5.26%, Mylan fell 4.40% and Opko Health fell 4.01%, to make it a rout for the the pharmaceuticals sector. Notable advancers were Delek Group energy companies Avner, up 2.64%, and Delek Drilling, up 2.54%.
Published by Globes [online], Israel business news - www.globes-online.com - on August 25, 2016
© Copyright of Globes Publisher Itonut (1983) Ltd. 2016